Defective vasculature in fibronectin‐receptor‐deficient cho cell tumors in nude mice

International Journal of Cancer

Volumn 55, Issue 3, 1993, Pages 436-441

  Schreiner, C L ^a   Fisher, M ^a   Bauer, J ^a   Juliano, R L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN RECEPTOR; INTEGRIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CHO CELL; CONTROLLED STUDY; HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR XENOGRAFT;

ANIMAL; CHO CELLS; FIBRINOGEN; FIBRONECTINS; HAMSTERS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; RECEPTORS, FIBRONECTIN; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; VON WILLEBRAND FACTOR;

EID: 0027438931     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910550319     Document Type: Article

References (28)

1. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells
2. Cell surface receptors for extracellular matrix components
3. v integrin subunit
4. Motility of fibronectin receptor‐deficient cells on fibronectin and vitronectin: collaborative interactions among integrins
5. The functional role of the cytoplasmic domain of the alpha 5 subunit of the fibronectin receptor
6. Tumor interactions with the vasculature: angiogenesis and tumor metastasis
7. Selective inhibition of fibronectin mediated adhesion by monoclonal antibodies to a cell surface glycoprotein
8. Control of growth and differentiation of vascular cells by extracellular matrix proteins
9. Metachromasia and improved histological detail with toluidine blue‐hematoxylin and eosin
10. Elevated levels of alpha 5/beta 1 fibronectin receptor suppress the transformed phenotype in CHO cells
11. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4/beta 1
12. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis
13. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro
14. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis
15. Endothelial cell‐extracellular matrix interactions. Matrix as a modulator of cell function
16. Extracellular matrix assembly
17. Fibronectin's cell adhesive domain and an amino terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix
18. Subcellular platelet factor VIII antigen and von Willebrand factor
19. Inhibition of angiogenesis in vitro by Arg‐Gly‐Asp‐containing synthetic peptide
20. First steps of tumor‐related angiogenesis
21. Proteolytic balance and capillary morphogenesis
22. Changes in integrin receptors on oncogenically transformed cells
23. Identification and isolation of a 150 kD cell surface glycoprotein with properties expected of a fibronectin receptor
24. Basic fibroblast growth factor‐syndecan complex at cell surface or immobilized to matrix promotes growth
25. Isolation and characterization of Chinese hamster ovary cell variants deficient in the expression of fibronectin receptor
26. Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants
27. Identification of multiple cell adhesion receptors for collagen and fibronectin in human osteosarcoma cells possessing unique alpha and beta subunits